Meeting Information and Materials

Sept. 8, 2023

Sept. 8 Newborn Screening Technical Advisory Committee (TAC) Agenda Guanidinoacetate methyltransferase (GAMT) Deficiency and Arginase 1 Deficiency (ARG1-D) Meeting Materials
Agenda
Item #
Item
1-2

TAC Overview, Expectations, and Meeting Norms

Meeting Expectations and Meeting Norms Introduction Packet
State Board of Health Newborn Screening (NBS) Process and Criteria

GAMT Deficiency Overview 

Arginase 1 Deficiency (ARG1-D) Overview

3

NBS Program Overview

Department of Health NBS Program Presentation

4

NBS Criteria Review

State Board of Health NBS Criteria Overview

6

Natural History of GAMT Deficiency – Diagnostic Testing & Available Treatment

GAMT Natural History, Diagnostic Testing and Available Treatment

7

Available Screening Technology – GAMT Deficiency

Screening for GAMT Deficiency

8

Cost-Benefit Analysis – GAMT Deficiency

GAMT Deficiency Cost-Benefit Analysis
GAMT Deficiency Cost-Benefit Analysis Written Narrative

15

Natural History of ARG1-D – Diagnostic Testing & Available Treatment

ARG1-D Natural History, Diagnostic Testing & Available

16

Available Screening Technology – ARG1-D

Screening for ARG1-D

17

Cost-Benefit Analysis – ARG1-D

ARG1-D Cost Benefit Analysis
ARG1-D Cost Benefit Analysis Written Narrative